Barclays (NYSE:BCS) reported quarterly earnings of $0.27 per share. This is a 60.29 percent decrease over earnings of $0.68 per share from the same period last year. The company reported $7.15 billion in sales this
Curis, Inc. (NASDAQ:CRIS), a biotechnology company focused on the development of innovative therapeutics for the treatment of cancer, today announced that the U.S. Food and Drug Administration (FDA) has placed a partial